V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000670 | 230000391 | 0 | 0 | Adjuvant (A) | 2015-11-03 | 2015-11-03 | CAPECITABINE + RT | 02 | N | 230008950 | DOXORUBICIN |
| 230000671 | 230000392 | null | 73.6 | Adjuvant (A) | 2017-11-20 | 2017-12-18 | Oxaliplatin + Modified de Gramont | 02 | N | 230008969 | SORAFENIB |
| 230000672 | 230001199 | 1.7 | null | Adjuvant (A) | 2017-04-24 | 2017-04-25 | Oxaliplatin + Modified de Gramont | N | null | 230009054 | OXALIPLATIN + MDG |
| 230000673 | 230001199 | 1.59 | 89 | Adjuvant (A) | 2014-06-06 | 2014-06-06 | EOX | 02 | null | 230009054 | OXALIPLATIN + MDG |
| 230000674 | 230000393 | 1.63 | 51.2 | Curative (C) | 2018-02-12 | 2018-02-12 | TEMOZOLOMIDE | N | null | 230009120 | PACLITAXEL |
| 230000675 | 230001200 | 1.68 | 58.1 | Palliative (P) | 2017-09-11 | 2017-09-19 | Irinotecan + Modified De Gramont | 2 | N | 230009139 | PEMBROLIZUMAB |
| 230000676 | 230001519 | 1.68 | 43.2 | Adjuvant (A) | 2018-08-30 | 2018-09-08 | Fluorouricil + Folonic Acid (MdG) | N | N | 230009178 | GEMCITABINE |
| 230000677 | 230001662 | 1.67 | 53.1 | Palliative (P) | 2017-04-21 | 2017-04-22 | Irinotecan + Modified De Gramont | 02 | N | 230009232 | TRASTUZUMAB |
| 230000678 | 230000394 | null | 53.6 | null | 2013-07-03 | 2013-10-13 | Capecitabine 35days + RT | null | null | 230009246 | SORAFENIB |
| 230000679 | 230000395 | null | 64.25 | Palliative (P) | 2016-06-07 | 2016-07-17 | Cisplatin + Radiotherapy | null | N | 230009272 | VANDETANIB |
| 230000680 | 230000396 | 1.76 | 73.2 | Palliative (P) | 2019-03-25 | 2019-03-29 | Carboplatin AUC 2 - 5 | 02 | N | 230009388 | CARBOPLATIN + ETOPOSIDE |
| 230000681 | 230000396 | 1.7 | 96.5 | Palliative (P) | 2018-10-06 | 2018-10-17 | CAPECITABINE + OXALIPLATIN | N | N | 230009388 | Y-90 |
| 230000682 | 230001520 | 1.69 | 0 | Palliative (P) | 2017-11-28 | 2017-12-15 | EC | N | N | 230009458 | CISPLATIN + DOXORUBICIN |
| 230000683 | 230001520 | 1.47 | null | Disease modification (D) | 2013-05-29 | 2013-06-09 | Oxaliplatin + Modified de Gramont | N | N | 230009458 | DOCETAXEL |
| 230000684 | 230001520 | 1.57 | 57.5 | Palliative (P) | 2018-12-17 | 2018-12-18 | CARBOPLATIN | N | N | 230009458 | VANDETANIB |
| 230000685 | 230000397 | 1.63 | 68.2 | Palliative (P) | 2014-08-25 | 2014-08-29 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 230009647 | FLUOROURACIL + MITOMYCIN + RT |
| 230000686 | 230000398 | 1.64 | 96.5 | Curative (C) | 2016-01-26 | 2016-02-23 | Carboplatin + Pemetrexed | 02 | Y | 230009672 | CARBOPLATIN + PACLITAXEL |
| 230000687 | 230000398 | null | 77.8 | Adjuvant (A) | 2018-03-10 | 2018-03-16 | Capecitabine + Oxaliplatin 21day | N | null | 230009672 | CISPLATIN + VINORELBINE |
| 230000688 | 230000399 | 1.85 | 113 | Adjuvant (A) | 2012-07-13 | 2012-07-21 | Carboplatin + Docetaxel | N | N | 230009738 | CARBOPLATIN + ETOPOSIDE |
| 230000689 | 230000400 | null | 81 | Palliative (P) | 2015-01-28 | 2015-01-28 | FEC 100 | N | N | 230009744 | OXALIPLATIN + MDG |
| 230000690 | 230000401 | 0 | 65 | Curative (C) | 2018-09-26 | 2018-09-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | 230009779 | CHOP R |
| 230000691 | 230000402 | null | 56.9 | Adjuvant (A) | 2018-03-06 | 2018-04-18 | FLUOROURACIL + MITOMYCIN | N | null | 230009940 | CAPECITABINE + TRASTUZUMAB |
| 230000692 | 230000402 | 1.6 | null | Adjuvant (A) | 2016-11-16 | 2016-11-20 | Capecitabine + Oxaliplatin 21day | N | N | 230009940 | LANREOTIDE |
| 230000693 | 230000403 | 1.7 | 58 | Neo-adjuvant (N) | 2018-12-14 | 2018-12-16 | Capecitabine | 2 | Y | 230009950 | CVP R |
| 230000694 | 230001204 | 1.55 | 57.5 | Curative (C) | 2017-04-07 | 2017-04-21 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 230010049 | CAPECITABINE |
| 230000695 | 230000404 | 1.65 | 54.8 | null | 2017-01-07 | 2017-01-10 | Oxaliplatin + Modified de Gramont | 02 | null | 230010052 | AFATINIB |
| 230000696 | 230000405 | 1.82 | 100.1 | Curative (C) | 2014-12-29 | 2015-01-01 | Abiraterone | 2 | Y | 230010075 | EOX |
| 230000697 | 230000406 | 1.67 | 56.4 | Palliative (P) | 2017-11-24 | 2017-11-24 | RUXOLITINIB | 1 | N | 230010199 | DOCETAXEL |
| 230000698 | 230000406 | 1.7 | null | Disease modification (D) | 2017-10-12 | 2017-10-19 | Carboplatin + Docetaxel | null | N | 230010199 | FLUOROURACIL + MITOMYCIN + RT |
| 230000699 | 230000406 | 1.53 | 68 | Adjuvant (A) | 2014-12-22 | 2015-01-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | Y | 230010199 | CISPLATIN |
| 230000700 | 230000407 | null | 93.6 | Palliative (P) | 2018-06-13 | 2018-07-12 | Capecitabine | N | null | 230010315 | CHLORAMBUCIL + RITUXIMAB |
| 230000701 | 230000408 | 1.7 | 58.9 | Adjuvant (A) | 2016-01-05 | 2016-01-20 | Cyclophosphamide + Docetaxel | 2 | N | 230010317 | GEMCARBO |
| 230000702 | 230000409 | 1.49 | 81.8 | Palliative (P) | 2015-04-10 | 2015-04-18 | VANDETANIB | 02 | N | 230010381 | CISPLATIN + FLUOROURACIL + RT |
| 230000703 | 230000410 | 1.73 | null | Adjuvant (A) | 2018-07-01 | 2018-07-19 | Irinotecan + Modified De Gramont | N | N | 230010402 | SORAFENIB |
| 230000704 | 230000411 | 1.6 | 63.3 | Palliative (P) | null | 2016-11-05 | Capecitabine | N | N | 230010413 | CAPECITABINE |
| 230000705 | 230000412 | 1.61 | 60.7 | Adjuvant (A) | null | 2015-08-27 | CAPECITABINE + RT | N | N | 230010503 | TRIAL |
| 230000706 | 230000413 | 1.83 | 69 | Palliative (P) | 2018-06-21 | 2018-07-18 | VANDETANIB | N | N | 230010598 | CAPECITABINE |
| 230000707 | 230000414 | 1.59 | 0 | Palliative (P) | 2015-05-11 | 2015-05-20 | Capecitabine + Oxaliplatin 21day | N | N | 230010638 | CISPLATIN + VINORELBINE |
| 230000708 | 230000415 | 1.77 | 85.2 | Curative (C) | 2018-09-24 | 2018-09-26 | GEMCITABINE | 02 | N | 230010735 | CISPLATIN + RT |
| 230000709 | 230000416 | 1.58 | null | Palliative (P) | 2016-08-30 | 2016-09-21 | VANDETANIB | N | N | 230010751 | CISPLATIN + RT |
| 230000710 | 230000417 | 1.79 | 81 | Adjuvant (A) | 2017-01-09 | 2017-01-09 | Capecitabine + Oxaliplatin 21day | 02 | N | 230010756 | SORAFENIB |
| 230000711 | 230000418 | 1.65 | 62.2 | Curative (C) | 2014-03-09 | 2014-03-09 | CAPECITABINE + RT | N | Y | 230010837 | CISPLATIN + RT |
| 230000712 | 230000419 | 1.72 | 108.5 | null | 2015-11-24 | 2015-11-25 | Capecitabine + Oxaliplatin 14day | N | null | 230010936 | CISPLATIN + DOXORUBICIN |
| 230000713 | 230000420 | null | 66 | Adjuvant (A) | 2017-04-03 | 2017-04-04 | PACLITAXEL | N | N | 230011067 | PAZOPANIB |
| 230000714 | 230000420 | 1.65 | 45.2 | Adjuvant (A) | 2017-09-25 | 2017-09-25 | Capecitabine | 02 | N | 230011067 | DOCETAXEL |
| 230000715 | 230000421 | 1.64 | 82 | Disease modification (D) | 2014-08-07 | 2014-08-13 | CHOP R | N | Y | 230011103 | CISPLATIN + PEMETREXED |
| 230000716 | 230000422 | 1.81 | 84.5 | Curative (C) | 2019-01-15 | 2019-02-12 | ABVD | 02 | Y | 230011124 | VANDETANIB |
| 230000717 | 230000422 | 1.59 | 90.6 | Curative (C) | 2017-04-17 | 2017-04-27 | Cisplatin + Doxorubicin | 02 | N | 230011124 | SORAFENIB |
| 230000718 | 230001522 | 1.7 | 99.3 | Palliative (P) | 2016-09-09 | 2016-09-15 | SCOT TRIAL | 02 | N | 230011221 | TEMOZOLOMIDE |
| 230000719 | 230000423 | 1.53 | 76.2 | Neo-adjuvant (N) | 2016-09-29 | 2016-10-21 | CISPLATIN + RT | 02 | N | 230011433 | FLUOROURACIL + MITOMYCIN + RT |